ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,192.00
      -0.44%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.825
      0.34%
      Bitcoin
      62,602.51
      -0.39%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. FibroGen Inc (FGEN)

      7. FibroGen Inc (FGEN) News

      FGEN

      FibroGen (FGEN)

      FibroGen Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FGEN
      DateTimeSourceHeadlineSymbolCompany
      09/01/20237:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
      09/01/20237:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
      09/01/20235:31PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FGENFibroGen Inc
      08/29/20235:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
      08/29/20234:15PMGlobeNewswire Inc.FibroGen Announces Topline Results from LELANTOS-2, a Phase 3 Clinical Study of Pamrevlumab in Ambulatory Duchenne Muscular DystrophyNASDAQ:FGENFibroGen Inc
      08/14/20235:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
      08/09/20235:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
      08/08/20237:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
      08/07/20234:22PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FGENFibroGen Inc
      08/07/20234:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FGENFibroGen Inc
      08/07/20234:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
      08/07/20234:01PMGlobeNewswire Inc.FibroGen Reports Second Quarter 2023 Financial ResultsNASDAQ:FGENFibroGen Inc
      08/04/20234:42PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FGENFibroGen Inc
      07/25/20238:32AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
      07/25/20237:00AMGlobeNewswire Inc.FibroGen Announces Leadership TransitionNASDAQ:FGENFibroGen Inc
      07/24/20237:00AMGlobeNewswire Inc.FibroGen to Report Second Quarter 2023 Financial ResultsNASDAQ:FGENFibroGen Inc
      07/19/20234:47PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:FGENFibroGen Inc
      07/19/20237:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
      07/13/20238:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
      07/11/20234:46PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:FGENFibroGen Inc
      07/10/20237:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
      06/26/20234:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      06/26/20239:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FGENFibroGen Inc
      06/26/20237:04AMGlobeNewswire Inc.FibroGen Announces Topline Results from Phase 3 ZEPHYRUS-1 Study of Pamrevlumab for the Treatment of Idiopathic Pulmonary FibrosisNASDAQ:FGENFibroGen Inc
      06/09/20237:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      06/09/20237:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      06/09/20237:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      06/09/20237:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      06/09/20237:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
      06/09/20237:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FGENFibroGen Inc
       Showing the most relevant articles for your search:NASDAQ:FGEN